Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00212797 | A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845) | PHASE2 | COMPLETED | 273 | — | — | Jul 1, 2004 | Jul 1, 2006 | Nov 26, 2015 | - | — |
| Arm | Type | Description |
|---|---|---|
| Org 34517_1 | EXPERIMENTAL | low dose Org 34517 |
| Org 34517_2 | EXPERIMENTAL | high dose Org 34517 |
| Placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Org 34517 | DRUG | low dose Org 34517 |
| Placebo | DRUG | placebo |
Inclusion Criteria: * have provided voluntary written informed consent for trial participation after the scope and nature of the investigation were explained to them, and before starting any trial-related activities (before Screening); * be able to speak, read, understand, respond to questions, and...